Gilder Gagnon Howe & Co’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-37,578
| Closed | -$700K | – | 432 |
|
|
2021
Q3 | $700K | Sell |
37,578
-62
| -0.2% | -$1.16K | ﹤0.01% | 336 |
|
|
2021
Q2 | $798K | Sell |
37,640
-184
| -0.5% | -$3.9K | ﹤0.01% | 340 |
|
|
2021
Q1 | $768K | Sell |
37,824
-3,179
| -8% | -$64.5K | ﹤0.01% | 307 |
|
|
2020
Q4 | $1.09M | Sell |
41,003
-2,407
| -6% | -$63.9K | 0.01% | 265 |
|
|
2020
Q3 | $972K | Buy |
+43,410
| New | +$972K | 0.01% | 261 |
|